Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko, Erik, Steven Yeh, Stephen Foster, Uwe Pleyer, Mitchell Brigell, Cynthia Grosskreutz, and AIN457A2208 Study Group. 2015. “Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy.”. Ophthalmology 122 (5): 939-48.